Pages that link to "Q30311986"

The following pages link to Mechanisms of Osteoblastic Metastases: Role of Endothelin-1 (Q30311986):

Displaying 24 items.

• Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects (Q24814334) (← links)
• Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics (Q26773613) (← links)
• Pathogenesis of bone metastasis: a review (Q33993282) (← links)
• Cytotoxic effect of clodronate and zoledronate on the chondrosarcoma cell lines HTB-94 and CAL-78 (Q35197773) (← links)
• Breast cancer cells promote osteoblastic differentiation via Sema 3A signaling pathway in vitro (Q35406039) (← links)
• Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms (Q35609965) (← links)
• Metastasis suppressors and their roles in breast carcinoma (Q35981102) (← links)
• Mechanisms of cancer metastasis to the bone (Q36027386) (← links)
• A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions (Q36179414) (← links)
• New paradigms for therapy for osteosarcoma (Q36284671) (← links)
• Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach (Q36512574) (← links)
• Bone and prostate cancer cell interactions in metastatic prostate cancer (Q36682278) (← links)
• Combined exposure to big endothelin-1 and mechanical loading in bovine sternal cores promotes osteogenesis (Q36689469) (← links)
• Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies. (Q36731426) (← links)
• The Association of Endothelin-1 Signaling with Bone Alkaline Phosphatase Expression and Protumorigenic Activities in Canine Osteosarcoma (Q36975672) (← links)
• Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments. (Q37187646) (← links)
• Luminal breast cancer metastasis is dependent on estrogen signaling (Q37276323) (← links)
• Differences of osteoblastic bone metastases and osteolytic bone metastases in clinical features and molecular characteristics (Q38263353) (← links)
• Bone Pain and Muscle Weakness in Cancer Patients (Q38684768) (← links)
• Endothelin Signaling in Bone (Q38764798) (← links)
• Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer (Q42082392) (← links)
• Endothelin signaling regulates mineralization and posttranscriptionally regulates SOST in TMOb cells via miR 126-3p (Q42319588) (← links)
• WITHDRAWN: Endothelin signaling in bone (Q48025790) (← links)
• Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy (Q92636843) (← links)